Xenetic Biosciences (XBIO) Proxy Filing summary

Executive summary

• Annual meeting scheduled for December 11, 2024, to be held virtually for shareholder participation.

• Shareholders are encouraged to review proxy materials and vote by December 10, 2024.

Voting matters and shareholder proposals

• Election of six directors: Grigory Borisenko, Firdaus Jal Dastoor, Dmitry Genkin, Roger Kornberg, Moshe Mizrahy, and Alexey Vinogradov, with board recommending a vote for all.

• Ratification of Marcum LLP as independent registered public accounting firm for fiscal year ending December 31, 2024.

• Non-binding advisory vote to approve named executive officer compensation.

• Non-binding advisory vote on the frequency of future executive compensation votes ("Say on Frequency").

• Proxy holders authorized to vote on other business arising at the meeting.

Board of directors and corporate governance

• Six director nominees presented for election at the annual meeting.